Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-12 04:31:30 EDT

Explore

PostsPeople
LatestRanked
Load more
@abangelabs.bsky.socialOct 2, 2026, 12:03 PM

EMA sets 2026 year-end submission dates for Type I variations, helping regulatory teams plan upcoming filings. #HTA #RegulatoryAffairs #Pharma https://www.mattheneus.com/editorial/ema-type-i-variation-end-year-submission-dates-2026-10-01

@abangelabs.bsky.socialOct 2, 2026, 9:02 AM

Sweden’s Alhemo decision shows how HTA can reconcile a difficult bleeding endpoint with cost evidence. https://www.mattheneus.com/editorial/tlv-alhemo-concizumab-haemophilia-b-explorer8-cost-comparison-2026-10-02 #HTA #HealthEconomics #Pharma

@longevitytech.bsky.socialOct 2, 2026, 8:23 AM

What could pharma’s shift towards prevention mean for therapeutics?

The Longevity Biotech Report 2026 tracks $30bn+ invested, 3,036 therapeutics and 781 companies shaping the market.

Access the report free. Link in the comment.

Sponsored by MuseCell Innovations.

#Longevity #Pharma #Biotech

@abangelabs.bsky.socialOct 2, 2026, 8:03 AM

Germany’s G-BA found Lynkuet’s added benefit unproven in both menopause subgroups. Read the final resolution: https://www.mattheneus.com/editorial/g-ba-lynkuet-oasis3-final-resolution-2026-10-01 #HTA #RegulatoryAffairs #Pharma

@4040rec.bsky.socialOct 2, 2026, 7:59 AM

#FridayFeeling #FridayVibes #FridayMotivation #fridaymorning #Friday #4040rec #medicalsales #marketing #marketaccess #leadership #recruitment #talentacquisition #UKJobs #medicalequipment #medicalconsumables #medicaldevices #pharma #healthcare #biotech #medtech #lifesciences #healthcaresales

@drtimos.bsky.socialOct 2, 2026, 5:28 AM

Signal or noise? > Axsome Therapeutics vs. Vertex Pharmaceuticals: Which
Biotech Stock Is a Better Buy in 2026? - The Motley Fool >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #biotech #pharma #pharmaceutical #healthcare

@abangelabs.bsky.socialOct 1, 2026, 9:03 PM

Global regulators are aligning on non-animal evidence and batch release, with practical implications for medicines development. #HTA #RegulatoryAffairs #Pharma https://www.mattheneus.com/editorial/mhra-icmra-non-animal-methods-batch-release-global-statement-2026-10-01

@dnanexus.bsky.socialOct 1, 2026, 8:33 PM

Come tell us what your data science team is blocked on at #ddpwest26. Our team is ready to answer your questions and demonstrate how we enable your omics data and enterprise data to interact in the same environment.

#DataScience #Pharma #Multiomics #DNAnexus

Join us at DataDrivenPharma West Conference! October 15-16, 2026 South San Francisco, CA
@drtimos.bsky.socialOct 1, 2026, 6:25 PM

Signal or noise? > AI Is Reshaping Gene Transfer Technologies — $258.7 Billion
in VC Signals a Structural Shift in Biotech Investment -
GlobeNewswire >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #pharmaceutical #biotech #healthcare

@freegardener.bsky.socialOct 1, 2026, 5:07 PM

AbbVie ships profitable medicines at scale while CRISPR bets on gene editing with no steady revenue. Two risk profiles that don't cancel out. #AbbVie #CRISPR #Biotech #Pharma

https://freegardner.com/sci_scout/abbvie-vs-crispr-therapeutics-pharma-comparison.html

@skillpad.bsky.socialOct 1, 2026, 4:10 PM

It’s the final day of #LifeSciencesFuture 2026!

There’s still time to come meet the Skillpad team & learn more about our digital learning for the #lifesciences industry.

Come say hello—we’d love to meet you!

#DigitalLearning #LifeSciencesTraining #biotech #elearning #training #pharma

@abangelabs.bsky.socialOct 1, 2026, 4:03 PM

UK approval extends Ocrevus access to children with relapsing-remitting multiple sclerosis. https://www.mattheneus.com/editorial/mhra-ocrevus-paediatric-rrms-access-work-sharing-operetta2-2026-09-21 #HTA #RegulatoryAffairs #Pharma

@abangelabs.bsky.socialOct 1, 2026, 4:02 PM

Sweden raised Rectogesic’s reimbursed price by 60.6% to protect supply continuity. https://www.mattheneus.com/editorial/tlv-rectogesic-price-increase-supply-continuity-gross-margin-2026-10-01 #HTA #Pharma #HealthEconomics

@pharmaphorum.bsky.socialOct 1, 2026, 3:44 PM

In today’s headlines: pharmaphorum.com/news #news #pharma #lifesciences #pharmanews #pharmaindustry

@midgardfinance.comOct 1, 2026, 3:30 PM

💉 #pharma #EASD2026

🇺🇸 $LLY #eloralintide added 8.5 points of weight loss to tirzepatide in type 2 diabetes: 23.3% vs 14.8%, 48 wk.

🇩🇰 $NOVO #CagriSema: 4.0 added to semaglutide, 14.2% vs 10.2%, 68 wk. One-molecule #zenagamtide: 14.6%, 36 wk.

Separate trials.

midgardfinance.com/diabetes/

Chart titled "Amylin added 8.5 points to tirzepatide, 4.0 to semaglutide". Three rows, each a separate trial in adults with type 2 diabetes, showing the average weight loss at the top dose as estimated for people staying on treatment. Top row, Lilly, two molecules, phase 2b, 48 weeks: a grey point for tirzepatide 15 mg alone at 14.8 per cent joined to a red point for the same dose with eloralintide 9 mg at 23.3 per cent. Middle row, Novo, two molecules, the REIMAGINE 2 trial, phase 3, 68 weeks: a grey point for semaglutide 2.4 mg alone at 10.2 per cent joined to a blue point for the same dose with cagrilintide 2.4 mg at 14.2 per cent. Bottom row, Novo, one molecule, phase 2, 36 weeks: a single blue point for zenagamtide 40 mg at 14.6 per cent, marked as having no arm without amylin, because both actions are in the same molecule. The rows are not a ranking: the trials differ in length, stage and participants, and only the gap inside a row compares like with like.
@thepharmacistnews.bsky.socialOct 1, 2026, 3:02 PM

Spending watchdog considering UK-US pharma deal investigation

buff.ly/U5jAkEQ

#UK #US #pharma #America #pharmaceuticals #lifesciences #pharmacy

@pharmalot.bsky.socialOct 1, 2026, 2:10 PM

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Trump's plan to lower Medicare drug prices, a Lilly obesity drug, and more news.. statnews.com/pharmalot/20... #pharma #Trump #Medicare #obesity #weight #layoffs #FDA #animals #Lilly #Novo #AstraZeneca #Sanofi #Regeneron

@midgardfinance.comOct 1, 2026, 2:00 PM

💊 #pharma #EASD2026

🇺🇸 $LLY #orforglipron, a daily pill, vs insulin glargine in type 2 diabetes at high CV risk (ACHIEVE-4, n=2,749): major CV events HR 0.84 (0.59-1.20). Non-inferior, not shown better.

Deaths HR 0.43 (0.25-0.75), not a formally tested endpoint.

midgardfinance.com/diabetes/

Forest plot titled "Orforglipron pill vs insulin glargine", from Lilly's ACHIEVE-4 trial in 2,749 adults with type 2 diabetes, obesity or overweight and raised cardiovascular risk. Four hazard ratios with 95% intervals on a log axis from 0.2 to 2, with a vertical line at 1; below 1 favours the pill. MACE-4 (primary): 0.84 (0.59-1.20). MACE-3: 0.77 (0.52-1.13). Cardiovascular death: 0.47 (0.25-0.90). Death, any cause: 0.43 (0.25-0.75). The first two, drawn in grey, were the tested endpoints and their intervals cross 1: the pill met non-inferiority (limit 1.8) and was not shown to be better. The two death endpoints, in purple, sit below 1 but were not controlled for multiple testing. Open-label trial, median follow-up two years; the primary endpoint occurred in 57 of 1,358 on the pill and 67 of 1,343 on insulin. At week 52, counting all randomised patients, HbA1c fell 1.5 points on the pill and 1.0 on insulin; weight changed -7.8% and +1.1%.
@skillpad.bsky.socialOct 1, 2026, 12:21 PM

#LifeSciencesFuture 2026 is officially underway & we're ready to meet you.

If you’re attending, come say hello, meet the team, & learn more about Skillpad’s digital learning for the life sciences industry.

Come find us!

#elearning #training #pharma #biotechnology

View of Skillpad's promo marketing table at the Life Sciences Future event
@notexx.deOct 1, 2026, 11:00 AM

💊 Abnehmpillen beflügeln Pharmabranche

Seit September gibt es Wegovy von Novo Nordisk in Deutschland als Tablette. Der Wirkstoff Semaglutid bleibt gleich, die Kosten liegen bei 170 bis 280 Euro monatlich.

#Abnehmspritze #Pharma #NovoNordisk #EliLilly #Börse

💊 Abnehmpillen beflügeln Pharmabranche